Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program

J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e106-e108. doi: 10.1111/jdv.16833. Epub 2020 Aug 16.

Authors

D R Pease¹, M E Martinez-Escala¹, J Jimenez¹, J Guitart^{1

2}, D P West^{1

2}, B Nardone¹

Affiliations

¹ Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

PMID: 33480442
DOI: 10.1111/jdv.16833

No abstract available

Publication types

Letter

MeSH terms

Databases, Factual
Drug-Related Side Effects and Adverse Reactions*
Humans
Hydrochlorothiazide / adverse effects
Lymphoma, T-Cell, Cutaneous*
Pharmacovigilance
Skin Neoplasms*

Substances

Hydrochlorothiazide